Rapid COVID-19 test developed to detect neutralizing antibodies with high specificity and sensitivity

A unique and rapid SARS-CoV-2 surrogate virus neutralisation test (sVNT) may be the much needed boost to current COVID-19 investigations to determine infection rate, herd immunity, predicted humoral protection, and vaccine efficacy during clinical trials.